46 medicines held by Phoenix Labs on the Irish market, from the HPRA register of authorised products.
| Medicine | Active substance | Licence holder | Status |
|---|---|---|---|
| Anthisan Cream 2% w/w PA1113/024/001 |
Mepyramine maleate | Phoenix Labs | Marketed |
| Arthrimel 1500mg Film Coated Tablets PA1113/011/003 |
Glucosamine sulfate | Phoenix Labs | Not marketed |
| Arthrimel 500 mg Film-Coated Tablets PA1113/011/001 |
Glucosamine sulfate | Phoenix Labs | Not marketed |
| Arthrimel 750mg Film Coated Tablets PA1113/011/002 |
Glucosamine sulfate | Phoenix Labs | Marketed |
| Caneclear 150 mg hard capsule PA1113/013/001 |
Fluconazole | Phoenix Labs | Not marketed |
| Cetirelief Allergy 10 mg film-coated tablets PA1113/014/001 |
Cetirizine dihydrochloride | Phoenix Labs | Not marketed |
| Clareeze Allergy 10 mg Tablets PA1113/015/001 |
Loratadine | Phoenix Labs | Not marketed |
| Combileve 500 mg/200 mg film-coated tablets PA1113/032/001 |
Paracetamol, Ibuprofen | Phoenix Labs | Not marketed |
| DELTACORTRIL ENTERIC 2.5 mg gastro-resistant tablets PA1113/003/002 |
Prednisolone | Phoenix Labs | Marketed |
| DELTACORTRIL ENTERIC 5 mg gastro-resistant tablets PA1113/003/001 |
Prednisolone | Phoenix Labs | Marketed |
| Dentinox Infant Colic Drops 21 mg/2.5 ml Oral Suspension PA1113/021/001 |
Dimeticone, activated | Phoenix Labs | Marketed |
| Dioralyte Blackcurrant Powder for Oral Solution PA1113/025/001 |
Sodium chloride, Potassium chloride, Glucose, Disodium hydrogen citrate | Phoenix Labs | Marketed |
| Dioralyte Citrus Powder for Oral Solution PA1113/025/002 |
Glucose, Sodium chloride, Disodium hydrogen citrate, Potassium chloride | Phoenix Labs | Marketed |
| Dioralyte Natural, Powder for oral solution PA1113/026/001 |
Glucose, Sodium chloride, Potassium chloride, Disodium hydrogen citrate | Phoenix Labs | Marketed |
| Dioralyte Rebalance Blackcurrant Powder for Oral Solution PA1113/028/001 |
Sodium chloride, Potassium chloride, Glucose, Disodium hydrogen citrate | Phoenix Labs | — |
| Dioralyte Rebalance Citrus Powder for Oral Solution PA1113/028/002 |
Sodium chloride, Potassium chloride, Glucose, Disodium hydrogen citrate | Phoenix Labs | — |
| Dioralyte Rebalance Natural Powder for Oral Solution PA1113/028/003 |
Sodium chloride, Potassium chloride, Glucose, Disodium hydrogen citrate | Phoenix Labs | — |
| Diprobase Cream PA1113/030/001 |
Phoenix Labs | Not marketed | |
| Effentora 100 micrograms buccal tablets EU/1/08/441/1-2 |
FENTANYL CITRATE | Phoenix Labs | — |
| Effentora 200 micrograms buccal tablets EU/1/08/441/3-4 |
FENTANYL CITRATE | Phoenix Labs | — |
| Effentora 400 micrograms buccal tablets EU/1/08/441/5-6 |
FENTANYL CITRATE | Phoenix Labs | — |
| Effentora 600 micrograms buccal tablets EU/1/08/441/7-8 |
FENTANYL CITRATE | Phoenix Labs | — |
| Effentora 800 micrograms buccal tablets EU/1/08/441/9-10 |
FENTANYL CITRATE | Phoenix Labs | — |
| Etoflam 10% w/w gel PA1113/034/001 |
Etofenamate | Phoenix Labs | Not marketed |
| Etoflam 5% w/w Gel PA1113/002/001 |
Etofenamate | Phoenix Labs | Marketed |
| Famvir 125 mg film-coated tablets PA1113/018/001 |
Famciclovir | Phoenix Labs | Marketed |
| Famvir 250 mg film-coated tablets PA1113/018/002 |
Famciclovir | Phoenix Labs | Marketed |
| Famvir 500 mg film-coated tablets PA1113/018/003 |
Famciclovir | Phoenix Labs | Marketed |
| Medijel oromucosal gel Lidocaine hydrochloride 0.66% w/w Aminoacridine hydrochloride 0.05% w/w PA1113/022/001 |
Aminacrine hydrochloride, Lignocaine hydrochloride | Phoenix Labs | Marketed |
| Orosoothe 0.15% w/v Oromucosal Spray PA1113/016/001 |
BENZYDAMINE HYDROCHLORIDE | Phoenix Labs | — |
| Parvolex 200 mg/ml concentrate for Solution for Infusion PA1113/008/001 |
Acetylcysteine | Phoenix Labs | Marketed |
| Prednesol 5mg Tablets PA1113/001/001 |
Prednisolone | Phoenix Labs | Marketed |
| Proctosedyl Ointment PA1113/029/001 |
Hydrocortisone, Cinchocaine Hydrochloride, Aesculin, Framycetin sulphate | Phoenix Labs | Marketed |
| Sanomigran 1.5mg Tablets PA1113/012/002 |
Pizotifen | Phoenix Labs | Not marketed |
| Sanomigran 500 microgram Tablets PA1113/012/001 |
Pizotifen | Phoenix Labs | Not marketed |
| Solpadol 500 mg/30 mg Effervescent Tablets PA1113/027/002 |
Paracetamol, Codeine phosphate hemihydrate | Phoenix Labs | Marketed |
| Solpadol Caplets 500 mg/30 mg tablets PA1113/027/001 |
Paracetamol, Codeine phosphate hemihydrate | Phoenix Labs | Marketed |
| Uniflu Plus with Vitamin C Tablets PA1113/006/001 |
Paracetamol, Codeine phosphate hemihydrate, Diphenhydramine hydrochloride, Phenylephrine hydrochloride, Caffeine | Phoenix Labs | Marketed |
| Uniflu with Vitamin C Tablets PA1113/005/001 |
Caffeine, Diphenhydramine hydrochloride, Paracetamol, Phenylephrine hydrochloride, Ascorbic acid | Phoenix Labs | Marketed |
| Vitafen 100mg Film-coated Tablets PA1113/009/001 |
Aceclofenac | Phoenix Labs | Marketed |
| Warticon 0.15% w/w Cream PA1113/017/001 |
Podophyllotoxin | Phoenix Labs | Marketed |
| Zometa EU/1/01/176/004 |
Zoledronic acid | Phoenix Labs | — |
| Zometa 4 mg powder and solvent for solution for infusion EU/1/01/176/001 |
Zoledronic acid | Phoenix Labs | — |
| Zometa 4 mg powder and solvent for solution for infusion EU/1/01/176/002 |
Zoledronic acid | Phoenix Labs | — |
| Zometa 4 mg powder and solvent for solution for infusion EU/1/01/176/003 |
Zoledronic acid | Phoenix Labs | — |
| Zometa 4 mg/100 ml solution for infusion EU/1/01/176/007-009 |
Zoledronic acid monohydrate | Phoenix Labs | — |
Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.